What’s New with GBI Research's Premium Reports under the Pharmaceutical Industry

04 Oct 2011 • by Natalie Aster

Market Publishers Ltd informs that new GBI Research's Pharmaceutical Industry Reports have been added to its catalogue:

Immunoglobulins Market to 2017 - Off-Label Usage and Treatment of Primary Immunodeficiency Diseases and Neurological Disorders Stimulate Market Growth.

The immunoglobulins market is a steadily growing market and it is expected to grow steadily in the forecast period without any significant thrust due to a weak pipeline with few innovations. The existing promising immunoglobulins are undergoing life-cycle management, with them being approved for new indications. Immunoglobulins products are used in a host of diseases and conditions such as bone marrow transplants, hematological disorders, dermatology, rheumatology, infectious diseases, ophthalmology and obstetrics; however, PID and neuroimmunologic disorders, primarily CIDP, MMN and GBS, command the major share of the revenue from immunoglobulin therapies. Together they accounted for around 89% of the revenues from the seven indications for immunoglobulins for 2010.

Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline.

In 2010, the global coagulation disorders market was estimated to be worth $5.6 billion, representing a compound annual growth rate (CAGR) of 6.7% between 2002 and 2010. By 2017, the global coagulation disorders market is estimated to reach $8.3 billion, indicating a CAGR of 5.7% between 2010 and 2017. The major reason for the reduced growth rate is the expected decline in the annual cost of treating coagulation disorders after 2010. The global coagulation disorders market is expected to witness a series of patent expiries between 2010 and 2017, which includes most of the top selling blockbuster drugs in the hemophilia disease markets.While the current coagulation disorders pipeline does offer some promising products, the revenues generated from these products are not expected to completely offset the revenue lost due to the patent expiries. Therefore, the overall market growth of the global coagulation disorders market is expected to slow down in the future.

Published: Sept, 2011
Per Report Price: $3,500 (Single User License)

More new market research reports by GBI Research can be found at https://marketpublishers.com/members/gbiresearch/info.html

To order the report or ask for sample pages contact ps@marketpublishers.com


The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970